Life Science Company News

Results 401 - 420 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders

By: GlobeNewswire - 30 Apr 2024

Related companies: Beacon Biosignals, Inc.

Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers

By: GlobeNewswire - 30 Apr 2024

Kamari Pharma Appoints Dr. John Doux to its Board of Directors

By: GlobeNewswire - 30 Apr 2024

Related companies: Kamari Pharma

WeightWatchers Hosts ‘Making The Shift: A New Way to Think About Weight,’ A Live Virtual Event with Oprah Winfrey on Thursday, May 9

By: GlobeNewswire - 30 Apr 2024

Related companies: WW International, Inc.

Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients

By: GlobeNewswire - 30 Apr 2024

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand

By: GlobeNewswire - 30 Apr 2024

Resolutions of Annual Geneal Meeting

By: GlobeNewswire - 30 Apr 2024

Related companies: BioPorto Diagnostics A/S

RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine

By: GlobeNewswire - 30 Apr 2024

Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases

By: GlobeNewswire - 30 Apr 2024

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

By: GlobeNewswire - 30 Apr 2024

Related companies: Renovaro Inc.

Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management

By: GlobeNewswire - 30 Apr 2024

Related companies: Medicenna Therapeutics Corp.

Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

By: GlobeNewswire - 30 Apr 2024

Related companies: Biodexa Pharmaceuticals PLC

Press Release: Annual General Meeting of April 30, 2024

By: GlobeNewswire - 30 Apr 2024

Related companies: Sanofi SA

Resolutions from the annual shareholders’ meeting 2024

By: GlobeNewswire - 30 Apr 2024

Related companies: Novozymes A/S

EssilorLuxottica: EssilorLuxottica 2024 Annual Shareholders’ Meeting, starting a new chapter of the Company’s history

By: GlobeNewswire - 30 Apr 2024

Related companies: EssilorLuxottica

AB Science announces a slight delay in the publication of its 2023 annual financial report

By: GlobeNewswire - 30 Apr 2024

Related companies: AB Science SA | AllianceBernstein L.P.

Synaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual Meeting

By: GlobeNewswire - 30 Apr 2024

Related companies: Synaptive Medical

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

By: GlobeNewswire - 30 Apr 2024

Related companies: XORTX Therapeutics Inc

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

By: GlobeNewswire - 30 Apr 2024

Related companies: BioSig Technologies, Inc.

A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs

By: PR Newswire Association LLC. - 30 Apr 2024

Related companies: Leads Biolabs, Inc.

Results 401 - 420 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »